Another study which found a high prevalence of IBD was that of the Norwegian IBSEN group 8, 12 which found that 61.5% of those in their study had UC, 28.1% had CD and 10.5% had IBDU. In our series 3.5% of the patients had this last diagnosis.
Otros estudios con mayor prevalencia de enfermedad inflamatoria intestinal como el grupo IBSEN noruego 8, 12, reportan 61,5% de paciente con colitis ulcerativa, 28,1% con enfermedad de Crohn y 10,5% de colitis indeterminada o no clasificada, en nuestra serie la proporción de este último diagnóstico fue de 3,5%.